您的位置: 首页 > 农业专利 > 详情页

ENHANCING ENDONUCLEASE BASED GENE EDITING IN PRIMARY CELLS
专利权人:
Seattle Children's Hospital (dba Seattle Children's Research Institute)
发明人:
Andrew Scharenberg,David Rawlings,Michael C. Jensen,Kamila Gwiazda,Alexandra Grier
申请号:
US15152960
公开号:
US20160333377A1
申请日:
2016.05.12
申请国别(地区):
US
年份:
2016
代理人:
摘要:
Disclosed herein are nuclease-based systems for genome editing and methods of using the system for genome editing. Also, disclosed are approaches to enhance Cas9-mediated gene editing efficiency in primary human cells with minimal toxicity when using adeno-associated virus vectors (AAV) to express the guide RNAs necessary for CRISPR/Cas9-based genome editing in the presence of helper proteins.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充